ArticleFrontiers in pharmacology2021

Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan.

Ko-Jen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.